Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04530539 · ClinicalTrials.gov registry record · NA
The Effect of Melatonin and Vitamin C on COVID-19
A NA study, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT04530539 is a NA study that has completed, run by Lancaster General Hospital. The registered enrollment target is 122 participants.
The verdict
NCT04530539, a NA study, has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
This is a double-blind placebo controlled trial that seeks to evaluate the impact of melatonin and vitamin C on symptoms and outcomes of patients with COVID-19.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT melatonin
- DIETARY_SUPPLEMENT Vitamin C
- OTHER Symptom Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2022-08-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04530539
The ClinicalTrials.gov registry entry for NCT04530539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT04530539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04530539 about?
NCT04530539 is a clinical study titled "The Effect of Melatonin and Vitamin C on COVID-19". This is a double-blind placebo controlled trial that seeks to evaluate the impact of melatonin and vitamin C on symptoms and outcomes of patients with COVID-19.
What is the current status of trial NCT04530539?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2020-10-05. Estimated completion is 2022-08-11.
What interventions are being tested in trial NCT04530539?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), melatonin (DIETARY_SUPPLEMENT), Vitamin C (DIETARY_SUPPLEMENT), Symptom Survey (OTHER).
Who is sponsoring clinical trial NCT04530539?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.